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nergy homeostasis is an important physiological mechanism essential for balancing 
energy flow through the living systems by managing overall metabolism in the body. 
Thus, energy homeostasis is under a tight control by means of extremely well-regulated energy 
metabolism. One of the most common metabolic disorders that occur following disruption in 
energy homeostasis mechanisms is obesity. Obese individuals develop insulin resistance in the 
peripheral tissues (fat and muscle) and may also include non-alcoholic fatty liver disease. Insulin 
resistance is the primary factor responsible for the development of type 2 diabetes mellitus 
(T2D). Towards control and management of T2D condition, insulin, drugs that regulate the 
insulin sensitivity and drugs that regulate glucose metabolism are widely used. Repeated insulin 
administration is painful, expensive and requires constant glucose monitoring while other drugs 
have various limitations and side effects. Therefore, there is wide scope development of new 
anti-diabetic molecules for effective management of T2D. Studies related to energy metabolism 
are necessary to understand the cause of such disorders and improve existing methods to manage 
metabolic abnormalities. Animal models to understand such metabolic disorders have been 
developed by chemical treatments and genetic modifications, but diet-induced obese (DIO) 
animal models appear to be the better among all the models reported. DIO animal models are 
known to most closely mimic the physiological situation. Apart from the experimental model 
system studies have been conducted under physiological conditions to gain knowledge on 
possible mechanisms behind energy balance maintained and established during extreme 
situations such as pregnancy and lactation. To support fetal growth and milk synthesis several 
metabolic adjustments occur during pregnancy and lactation without the major disruption in the 
maternal energy homeostasis.  
In the present study, to gain knowledge on the mother’s body glucose, lipid management and 
insulin responses throughout the gestation and lactation periods analyses were carried out during 
at different stages of pregnancy and lactation in rats. It was observed that during pregnancy, the 
dam developed insulin resistance in peripheral tissues with decreased activation of insulin 
pathway and reduced glucose utilization while the liver remained unaffected. Although, as soon 
E 
GLUCOSE AND LIPID METABOLISM DURING PREGNANCY AND 
LACTATION IN RATS: ROLE OF UNDERCARBOXYLATED OSTEOCALCIN Synopsis 
6 
 
as the lactation began, peripheral tissue such as muscle developed increased insulin sensitivity 
associated with increased expression of glucose transporter gene and higher glucose metabolism. 
The reversal of insulin response in the muscle tissue observed during lactation appears to be a 
suitable model system for understanding the process by which the body undergoes a transition 
from insulin resistant state to sensitive state under a physiological condition. Interestingly, early 
lactation period is known to have much lower levels of insulin available to act upon peripheral 
tissues. Factors involved in this transition could be potential therapeutic agents for control of 
T2D, since during early stages of T2D muscle appears to be the first metabolic organ to exhibit 
resistance to insulin. The undercarboxylated osteocalcin (UNOC) has been reported to function 
as anti-diabetic molecule. UNOC is released from skeletal system during bone turnover, 
especially due to resorption process. Experiments were carried out to examine the role of UNOC 
during the transition from insulin resistant state of pregnancy to sensitive state of lactation 
period. It was observed that UNOC levels were lower during pregnancy, but increased during 
early lactation (day 3 to 6 of lactation). The increased UNOC levels seen during early lactation 
was higher than the levels observed in non-pregnant, non-lactating (NPNL) rats and the UNOC 
levels decreased following removal of pups immediately after parturition. It was noted that 
altering UNOC levels during early lactation altered the insulin response of the whole body and 
muscle transporter-4 expression (glut4) of lactating rats. A significant increase in bone turnover 
was also observed during lactation compared to NPNL and pregnant rats. The data suggest that 
increased bone turnover leads to increased UNOC levels in blood during lactation. Estrogen is 
known as bone protector molecule which acts via its receptors, estrogen receptor α and β (ERα 
and β). It was reported that ERβ is a dominant regulator of estrogen signaling when both the 
receptors of estrogen i.e. ERα and ERβ coexist in the target tissue and estrogen levels are 
relatively higher. Compared to NPNL rats estrogen levels have shown to be higher during late 
pregnancy and lower during early lactation. It was observed that liver and adipose tissues largely 
express ERα, but the muscle showed expression of both the receptors in NPNL rats indicating 
that muscle is the metabolic tissue that may be modulated by both the receptors. It has been 
reported that ERβ suppresses ERα action on glut4 transcription in the myocytes. It is possible 
that the altered ERs ratio modulates glut4 expression during late pregnancy and early lactation. 
The receptor expression ratio data indicated that muscle is an ERβ dominant during late 
pregnancy, while it is ERα dominant during early lactation. Further, alteration in UNOC levels 
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during early lactation changed ERs ratio but not sufficient enough to alter the ER dominance, 
indicating lack of effect of UNOC on ER dominance during early lactation. Experiments were 
conducted to alter insulin sensitivity during early lactation to extrapolate physiological findings 
to a pathological condition of the DIO model by feeding rats with high-fat diet (HFD). During 
early lactation, HFD dams had lower insulin response, lower circulatory UNOC level and lower 
UNOC receptor (GPRC6A) expression in the muscle. Gene expression of muscle glut4 was 
lower in HFD rats and the tissue remained ERα dominant indicating no role of HFD on ERs ratio 
in muscle during early lactation.  
UNOC has been found to have negative effect on lipid accumulation. During pregnancy, lipid 
accumulation is one of the first events essential for proper fetal development. Since UNOC 
levels were suppressed during pregnancy, experiments were carried out to examine relevance of 
UNOC suppression on lipid accumulation during early pregnancy. For this purpose, 
pharmacological approaches were utilized to alter UNOC levels during early pregnancy. It was 
observed that the transient elevation of UNOC levels caused decrease in maternal fat depots 
without changing circulatory triacylglyceride (TAG) levels. In experiments that decreased 
UNOC levels in NPNL state to mimic lower levels of UNOC present during early pregnancy, it 
was found fat storage was higher and TG was found to be lowered in the circulation. These 
results indicate that UNOC can cause a reduction in fat accumulation and TG levels but UNOC 
effects on TG levels, was not observed during pregnancy. The data taken together suggest that 
suppression of UNOC is required for better fat deposition in the mother’s body. Although, some 
studies have indicated an insulin response transition occurring during pregnancy to lactation, but 
the factors involved in this transition have not been reported. This report discusses about the 
factors such as UNOC and ERs and their involvement in the transition process. UNOC role has 
been studied in genetically modified models and in metabolic disorders such as obesity model 
system and evidence for physiological role of UNOC would further support its candidature as 
anti-diabetic molecule. The present research work is the first report to detail relevance of UNOC 
in physiological conditions such as pregnancy and lactation for glucose and lipid management.  
 
 
 
